Renaissance Technologies’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.2K Buy
+11,790
New +$56.2K ﹤0.01% 3379
2024
Q3
Sell
-3,320
Closed -$16.6K 3904
2024
Q2
$16.6K Sell
3,320
-5,966
-64% -$29.9K ﹤0.01% 3399
2024
Q1
$128K Buy
9,286
+5,877
+172% +$81K ﹤0.01% 3326
2023
Q4
$30K Buy
+3,409
New +$30K ﹤0.01% 3534
2022
Q4
Sell
-1,290
Closed -$8K 4430
2022
Q3
$8K Buy
1,290
+190
+17% +$1.18K ﹤0.01% 3958
2022
Q2
$9K Buy
+1,100
New +$9K ﹤0.01% 4161